Arne Kroidl
LMU Klinikum(DE)German Center for Infection Research(DE)Institute of Medical Microbiology and Hygiene(DE)Ludwig-Maximilians-Universität München(DE)
Publications by Year
Research Areas
HIV Research and Treatment, HIV/AIDS Research and Interventions, SARS-CoV-2 and COVID-19 Research, HIV/AIDS drug development and treatment, HIV-related health complications and treatments
Most-Cited Works
- → Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial(2021)170 cited
- → Increased and Expedited Case Detection by Xpert MTB/RIF Assay in Childhood Tuberculosis: A Prospective Cohort Study(2012)148 cited
- → Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2(2021)130 cited
- → A Phase 1/2 Study of a Multiclade HIV‐1 DNA Plasmid Prime and Recombinant Adenovirus Serotype 5 Boost Vaccine in HIV‐Uninfected East Africans (RV 172)(2010)105 cited
- → Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers(2020)103 cited
- → Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis(1997)